Medifast, Inc. (MED) Reaches $169.49 After 8.00% Up Move; Ion Asset Management LTD Has Decreased Mellanox Technologies LTD (MLNX) Position By $6.31 Million

June 18, 2018 - By Darrin Black

Medifast, Inc. (NYSE:MED) Logo

The stock of Medifast, Inc. (NYSE:MED) is a huge mover today! The stock increased 3.76% or $6.14 during the last trading session, reaching $169.49. About 136,521 shares traded. Medifast, Inc. (NYSE:MED) has risen 238.34% since June 18, 2017 and is uptrending. It has outperformed by 225.77% the S&P500. Some Historical MED News: ; 06/03/2018 – Medifast 4Q Rev $78M; 03/05/2018 – Medifast 1Q EPS $1.01; 06/03/2018 – Medifast Sees 1Q Rev $88.5M-$91.5M; 03/05/2018 – MEDIFAST INC MED.N RAISES FY 2018 SHR VIEW TO $3.55 TO $3.65; 23/04/2018 – Gatheredtable software licensed by Medifast; 15/05/2018 – Engaged Capital Adds Finisar, Exits Medifast, Cuts NCR: 13F; 06/03/2018 – Medifast: Michael Hoer Nominated to Be a Board Director; 06/03/2018 – Medifast: Jeffrey Brown Will Succeed Connolly as Audit Committee Chair; 03/05/2018 – Medifast Raises FY View To Rev $385M-$395M; 03/05/2018 – Medifast Sees 2Q EPS 94c-EPS 97cThe move comes after 5 months positive chart setup for the $2.04B company. It was reported on Jun, 18 by We have $183.05 PT which if reached, will make NYSE:MED worth $163.52M more.

Ion Asset Management Ltd decreased Mellanox Technologies Ltd (MLNX) stake by 5.71% reported in 2018Q1 SEC filing. Ion Asset Management Ltd sold 87,577 shares as Mellanox Technologies Ltd (MLNX)’s stock rose 24.89%. The Ion Asset Management Ltd holds 1.45 million shares with $105.29M value, down from 1.53 million last quarter. Mellanox Technologies Ltd now has $4.42B valuation. The stock decreased 1.51% or $1.3 during the last trading session, reaching $84.6. About 427,705 shares traded. Mellanox Technologies, Ltd. (NASDAQ:MLNX) has risen 80.17% since June 18, 2017 and is uptrending. It has outperformed by 67.60% the S&P500. Some Historical MLNX News: ; 13/03/2018 – Broadcom for Xilinx, Mellanox? Or Just More Capital Returns? — Barron’s Blog; 07/03/2018 – /C O R R E C T l O N — Starboard Value LP/; 17/04/2018 – Mellanox Sees 2Q Non-GAAP Gross Margins 68.5%-69.5%; 17/04/2018 – MELLANOX TECHNOLOGIES LTD MLNX.O SEES QUARTERLY REVENUE $255 MLN TO $265 MLN; 19/03/2018 – Starboard Comments on Mellanox’s Decision to Delay the 2018 Annual Meeting; 07/03/2018 – Mellanox Plans Special Vote on Rules Amid Starboard Pressure; 09/04/2018 – MELLANOX TECHNOLOGIES LTD – CHINESE WEATHER RESEARCH INSTITUTE HAS SELECTED MELLANOX EDR 100 GIGABIT INFINIBAND SOLUTIONS; 14/05/2018 – Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Shareholders Vote “FOR” Both of Mellanox’s Best-In-Class; 17/04/2018 – Mellanox Achieves Record Quarterly Revenues; Updates 2018 Outlook; 12/03/2018 – Mellanox Urges Shareholders to Vote in Favor of Governance Proposals at May Extraordinary General Meeting

Among 21 analysts covering Mellanox Tech (NASDAQ:MLNX), 13 have Buy rating, 1 Sell and 7 Hold. Therefore 62% are positive. Mellanox Tech had 58 analyst reports since July 23, 2015 according to SRatingsIntel. The rating was upgraded by Barclays Capital to “Equal-Weight” on Tuesday, November 28. As per Wednesday, December 6, the company rating was maintained by Stifel Nicolaus. Stifel Nicolaus maintained Mellanox Technologies, Ltd. (NASDAQ:MLNX) on Monday, September 25 with “Buy” rating. The company was initiated on Thursday, September 24 by DA Davidson. The rating was upgraded by PiperJaffray on Friday, May 18 to “Overweight”. J.P. Morgan downgraded Mellanox Technologies, Ltd. (NASDAQ:MLNX) rating on Thursday, October 26. J.P. Morgan has “Hold” rating and $47.0 target. Stifel Nicolaus maintained Mellanox Technologies, Ltd. (NASDAQ:MLNX) rating on Thursday, January 18. Stifel Nicolaus has “Buy” rating and $80.0 target. Macquarie Research maintained Mellanox Technologies, Ltd. (NASDAQ:MLNX) on Thursday, March 24 with “Outperform” rating. The rating was maintained by Jefferies with “Sell” on Monday, July 10. On Monday, May 9 the stock rating was initiated by Brean Capital with “Buy”.

Analysts await Mellanox Technologies, Ltd. (NASDAQ:MLNX) to report earnings on July, 25. They expect $0.79 earnings per share, up 690.00% or $0.69 from last year’s $0.1 per share. MLNX’s profit will be $41.24 million for 26.77 P/E if the $0.79 EPS becomes a reality. After $0.70 actual earnings per share reported by Mellanox Technologies, Ltd. for the previous quarter, Wall Street now forecasts 12.86% EPS growth.

More notable recent Mellanox Technologies, Ltd. (NASDAQ:MLNX) news were published by: which released: “Reuters: Mellanox close to board member deal with Starboard” on June 18, 2018, also with their article: “5 Top Liquid Stocks for a Winning Portfolio” published on June 18, 2018, published: “Market Trends Toward New Normal in NEXEO SOLUTIONS, Mimecast, Mellanox Technologies, YY, Enerplus, and …” on June 04, 2018. More interesting news about Mellanox Technologies, Ltd. (NASDAQ:MLNX) were released by: and their article: “Knock Your SOX Off” published on June 05, 2018 as well as‘s news article titled: “Mellanox Shareholders Overwhelmingly Support Company’s Best-in-Class Governance Proposals” with publication date: May 24, 2018.

Since January 2, 2018, it had 7 buys, and 11 insider sales for $6.47 million activity. Shares for $355,000 were sold by Kagan Michael on Wednesday, March 7. The insider Waldman Eyal sold $128,825. $143,550 worth of stock was sold by Sultzbaugh Marc on Thursday, May 3. Dorchak Glenda also sold $356,815 worth of Mellanox Technologies, Ltd. (NASDAQ:MLNX) shares. $12,538 worth of Mellanox Technologies, Ltd. (NASDAQ:MLNX) was bought by Titinger Jorge. Shulman Yakov (Jacob) sold $157,340 worth of stock or 2,406 shares. Shares for $96,135 were bought by LACEY THOMAS A on Tuesday, January 23.

Investors sentiment increased to 2.09 in 2018 Q1. Its up 1.01, from 1.08 in 2017Q4. It improved, as 8 investors sold MLNX shares while 39 reduced holdings. 51 funds opened positions while 47 raised stakes. 35.98 million shares or 13.98% more from 31.57 million shares in 2017Q4 were reported. Teacher Retirement Systems Of Texas invested in 10,142 shares. 46,740 were accumulated by Glaxis Capital Mgmt Ltd Liability Com. Tokio Marine Asset Management Limited holds 19,400 shares or 0.25% of its portfolio. D E Shaw Communications accumulated 7,653 shares or 0% of the stock. Bogle Limited Partnership De owns 0.74% invested in Mellanox Technologies, Ltd. (NASDAQ:MLNX) for 134,419 shares. The New York-based Bluefin Trading Limited Liability has invested 0.12% in Mellanox Technologies, Ltd. (NASDAQ:MLNX). Tradewinds Ltd Llc holds 400 shares or 0.01% of its portfolio. Sphera Funds Mngmt owns 100,279 shares. Cookson Peirce reported 189,710 shares. Atlantic Tru Group Lc has 0% invested in Mellanox Technologies, Ltd. (NASDAQ:MLNX). Jericho Asset Mngmt Limited Partnership owns 708,278 shares for 2.82% of their portfolio. Point72 Asset Management Ltd Partnership has invested 0.03% in Mellanox Technologies, Ltd. (NASDAQ:MLNX). Cap Rech Glob Invsts accumulated 4.31M shares. Renaissance Tech Ltd invested in 0.03% or 395,683 shares. 476 are owned by Tower Rech Limited Liability (Trc).

Investors sentiment decreased to 1.28 in Q1 2018. Its down 0.05, from 1.33 in 2017Q4. It is negative, as 17 investors sold Medifast, Inc. shares while 63 reduced holdings. 52 funds opened positions while 50 raised stakes. 10.03 million shares or 1.93% less from 10.23 million shares in 2017Q4 were reported. Moreover, Gsa Prtn Llp has 0.03% invested in Medifast, Inc. (NYSE:MED). The Wisconsin-based Mason Street Limited Liability Company has invested 0.01% in Medifast, Inc. (NYSE:MED). Schroder Mgmt owns 9,200 shares or 0% of their US portfolio. Thrivent Financial For Lutherans accumulated 6,858 shares or 0% of the stock. Stifel Corp reported 9,861 shares or 0% of all its holdings. Ameritas Investment Prtnrs Inc reported 0% of its portfolio in Medifast, Inc. (NYSE:MED). 37,200 are held by Td Asset Inc. 6,900 are held by Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Investment Mgmt Corp. Intll Grp Inc holds 0% of its portfolio in Medifast, Inc. (NYSE:MED) for 6,775 shares. Great Lakes Advsr Llc holds 0.09% of its portfolio in Medifast, Inc. (NYSE:MED) for 38,542 shares. Deutsche Bankshares Ag holds 0% of its portfolio in Medifast, Inc. (NYSE:MED) for 78,165 shares. Driehaus Cap Management Ltd Company holds 76,832 shares or 0.25% of its portfolio. U S Glob Invsts Incorporated invested in 17,600 shares. Moreover, Great West Life Assurance Can has 0% invested in Medifast, Inc. (NYSE:MED) for 14,076 shares. Quantbot Technology Lp owns 38 shares.

Medifast, Inc., through its subsidiaries, produces, distributes, and sells weight loss, weight management, healthy living products, and other consumable health and diet products. The company has market cap of $2.04 billion. The firm offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, eggs, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape For Life, Flavors of Home, and Essential 1 brands, as well as Dual Fuel, a sports nutrition pilot program. It has a 60.75 P/E ratio. It also provides meal replacements comprising vitamins and minerals; and hydration products, as well as other nutrients for health purposes.

More recent Medifast, Inc. (NYSE:MED) news were published by: which released: “Medifast, Inc. Announces Quarterly Dividend” on June 14, 2018. Also published the news titled: “6 Defensive Stocks to Buy as Trade Tensions Flare Up” on June 18, 2018.‘s news article titled: “Detailed Research: Economic Perspectives on Dorchester Minerals, MEDIFAST INC, Sabra Healthcare REIT …” with publication date: May 30, 2018 was also an interesting one.

Since March 8, 2018, it had 0 buys, and 3 insider sales for $4.87 million activity. $727,600 worth of Medifast, Inc. (NYSE:MED) was sold by CONNOLLY CHARLES P. MACDONALD MICHAEL C sold $3.47M worth of stock.

Medifast, Inc. (NYSE:MED) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: